News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

This Pharma CEO Just Named A New Drug After Herself


12/27/2013 6:32:29 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Drug names are usually terrible. What I’ve heard from industry insiders is that their first and most mellifluous choices usually get rejected by the Food and Drug Administration, forcing them to go to their second- or third-favorite choices in order to launch their medicines on time. Which is what makes the name of Orenitram, the new drug approved by United Therapeutics , all the more impressive.

Hey, check out all the research scientist jobs. Post your resume today!

Read at Forbes

comments powered by Disqus
Forbes
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES